Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 04, 2026
Why Is Fidelity National Information Services (FIS) Stock Down -10.07% Today?

Why Is Fidelity National Information Services (FIS) Stock Down -10.07% Today?

Key Takeaways

  • FIS shares plunged approximately 10.07% in intraday trading on Monday, falling to $40.27 from a prior close of $44.78.
  • The primary catalyst was a cut to full-year 2026 revenue and profit guidance, despite the company posting a slight earnings beat for the second quarter.
  • Q3 2026 guidance also came in below Wall Street consensus, exacerbating investor concerns about near-term growth momentum.
  • Macroeconomic headwinds including geopolitical tensions and trade policy uncertainty were cited as factors weighing on client technology spending.
  • Trading volume was sharply elevated, signaling strong conviction behind the sell-off.
  • Traders are now watching for analyst downgrades and any further commentary around the demand environment heading into the second half of 2026.

Opening Summary

Fidelity National Information Services, Inc. (FIS), a global provider of financial technology solutions spanning banking, capital markets, and payments processing, saw its stock tumble roughly 10.07% on Monday. Shares dropped to $40.27 in intraday trading, down sharply from Friday's closing price of $44.78. The sell-off was driven by the company's decision to lower its full-year 2026 revenue and adjusted earnings forecasts, overshadowing a modest second-quarter earnings beat. The revised guidance, coupled with third-quarter projections that fell short of analyst expectations, triggered a broad retreat from the stock as investors recalibrated growth assumptions for the Jacksonville, Florida-based firm.

Earnings Beat Overshadowed by Guidance Cut

FIS reported second-quarter 2026 adjusted earnings of $1.48 per share, edging past the consensus estimate of $1.47 per share. Revenue for the quarter came in at $3.38 billion, in line with analyst expectations. While the headline numbers were respectable, the market's focus immediately shifted to the company's forward outlook.

For the third quarter of 2026, FIS guided adjusted earnings to a range of $1.58 to $1.62 per share, noticeably below the Wall Street consensus of $1.65. Revenue guidance of $3.41 billion to $3.44 billion also trailed the expected $3.52 billion. Perhaps more concerning to investors was the downward revision to the full-year forecast: the company now expects adjusted earnings of $6.15 to $6.24 per share, down from a prior range of $6.22 to $6.32, and full-year revenue of $13.63 billion to $13.70 billion, reduced from the earlier outlook of $13.77 billion to $13.85 billion. The combination of a modest top-and-bottom-line beat paired with decidedly cautious guidance created a textbook sell-the-news reaction.

Macroeconomic Uncertainty Weighs on Client Spending

Management pointed to broader economic uncertainty as a key factor behind the tempered outlook. Geopolitical tensions linked to the Iran conflict, along with ongoing U.S. trade policy turbulence, have prompted financial institutions and retailers to exercise greater caution around technology spending. This hesitancy is directly impacting demand for certain banking and capital-markets products within FIS's portfolio. While CEO Stephanie Ferris noted that banks continue to invest in technology modernization and artificial intelligence initiatives — a structural tailwind for the company — the near-term spending caution appears to be outweighing those secular trends in the current quarter.

Market Context and Trading Activity

The sell-off in FIS was accompanied by heavy trading volume. Friday's session had already seen roughly 10.98 million shares change hands, well above the stock's average daily volume of approximately 6.6 million shares, and Monday's intraday activity suggested continued elevated participation. The magnitude of the decline pushed FIS well below key psychological and technical levels, with the stock now trading closer to its 52-week low of $37.42 than to its 52-week high of $79.32. The sharp move lower also reflected a broader reset in valuations within the fintech and payments processing space, where growth expectations have been under scrutiny amid the uncertain macro environment.

What Comes Next for FIS

Looking ahead, investors will be closely monitoring whether the demand softness flagged by management proves transitory or signals a more prolonged slowdown in financial technology spending. The company's next quarterly report will be critical in assessing whether the reduced guidance was sufficiently conservative or if further downward revisions may be necessary. Analyst reactions in the coming days — including potential ratings changes and price target adjustments — will likely shape near-term sentiment. Additionally, any developments on the geopolitical or trade policy fronts that alter the macroeconomic outlook could rapidly shift the calculus for FIS and its peers. On the positive side, the sustained investment by banks in AI and digital modernization provides a potential floor for long-term demand, even as near-term cyclical headwinds persist. The stock's dividend yield, now above 4%, may also attract income-oriented investors during this period of price weakness.

Trending AI Robots

For traders seeking systematic approaches to navigate volatile markets like the current fintech landscape, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of automated trading bots covering thousands of tickers across various strategies, timeframes, and performance metrics. However, only the strongest performers under prevailing market conditions are featured in the Trending AI Robots section. Each bot differs by trading style, holding period, and the symbols it trades, giving users the flexibility to align with strategies that match their risk tolerance and market outlook.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FIS

FIS saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for FIS moved out of overbought territory on August 04, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 50 similar instances where the indicator exited the overbought zone. In of the 50 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FIS moved out of overbought territory on July 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FIS broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 27, 2026. You may want to consider a long position or call options on FIS as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FIS just turned positive on July 27, 2026. Looking at past instances where FIS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

FIS moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FIS crossed bullishly above the 50-day moving average on July 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FIS advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 211 cases where FIS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.426) is normal, around the industry mean (7.820). P/E Ratio (6.799) is within average values for comparable stocks, (71.183). Projected Growth (PEG Ratio) (0.245) is also within normal values, averaging (1.103). Dividend Yield (0.038) settles around the average of (0.025) among similar stocks. P/S Ratio (1.886) is also within normal values, averaging (148.701).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FIS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FIS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.42B. The market cap for tickers in the group ranges from 0 to 221.54B. IBM holds the highest valuation in this group at 221.54B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 8%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 59%. CYCU experienced the highest price growth at 177%, while DAIC experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 66
Price Growth Rating: 58
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
FIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of banking and payments technologies

Industry InformationTechnologyServices

Profile
Details
Industry
Data Processing Services
Address
347 Riverside Avenue
Phone
+1 904 438-6000
Employees
60000
Web
https://www.fisglobal.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.